These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 18230575

  • 1. [Imatinib and solid tumours].
    Arifi S, El Sayadi H, Dufresne A, Ray-Coquard I, Fayette J, Méeus P, Ranchère D, Decouvelaere AV, Alberti L, Tabone-Eglinger S, Blay JY, Cassier P.
    Bull Cancer; 2008 Jan; 95(1):99-106. PubMed ID: 18230575
    [Abstract] [Full Text] [Related]

  • 2. [New oncological treatment principle with imatinib].
    Kuenen BC, Pinedo HM.
    Ned Tijdschr Geneeskd; 2003 Oct 18; 147(42):2044-5. PubMed ID: 14606348
    [Abstract] [Full Text] [Related]

  • 3. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
    Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH.
    Gynecol Oncol; 2004 Oct 18; 95(1):32-6. PubMed ID: 15385107
    [Abstract] [Full Text] [Related]

  • 4. A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.
    Scheinfeld N.
    J Drugs Dermatol; 2006 Feb 18; 5(2):117-22. PubMed ID: 16485879
    [Abstract] [Full Text] [Related]

  • 5. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
    Demetri GD.
    Semin Oncol; 2001 Oct 18; 28(5 Suppl 17):19-26. PubMed ID: 11740803
    [Abstract] [Full Text] [Related]

  • 6. [Imatinib--a new perspective in the treatment of tumors].
    Klener P, Klamová H.
    Cas Lek Cesk; 2004 Oct 18; 143(9):579-80, 582-3. PubMed ID: 15532894
    [Abstract] [Full Text] [Related]

  • 7. Gastrointestinal stromal tumors and the evolution of targeted therapy.
    Sanborn RE, Blanke CD.
    Clin Adv Hematol Oncol; 2005 Aug 18; 3(8):647-57. PubMed ID: 16167051
    [Abstract] [Full Text] [Related]

  • 8. The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R.
    Gross DJ, Munter G, Bitan M, Siegal T, Gabizon A, Weitzen R, Merimsky O, Ackerstein A, Salmon A, Sella A, Slavin S, Israel Glivec in Solid Tumors Study Group.
    Endocr Relat Cancer; 2006 Jun 18; 13(2):535-40. PubMed ID: 16728580
    [Abstract] [Full Text] [Related]

  • 9. [Small-molecule inhibitors against KIT and PDGFRs especially in GISTs].
    Shiba K, Matsumoto T, Hirota S.
    Gan To Kagaku Ryoho; 2009 Jul 18; 36(7):1080-5. PubMed ID: 19620796
    [Abstract] [Full Text] [Related]

  • 10. [Clinical studies with imatinib in 2004].
    Eckhardt S.
    Orv Hetil; 2005 May 01; 146(18 Suppl 1):941-4. PubMed ID: 15921309
    [Abstract] [Full Text] [Related]

  • 11. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
    Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DM.
    Cancer; 2003 Aug 15; 98(4):758-64. PubMed ID: 12910520
    [Abstract] [Full Text] [Related]

  • 12. [Imatinib].
    Urabe A.
    Gan To Kagaku Ryoho; 2003 Aug 15; 30(8):1191-6. PubMed ID: 12938280
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The safety profile of imatinib in CML and GIST: long-term considerations.
    Thanopoulou E, Judson I.
    Arch Toxicol; 2012 Jan 15; 86(1):1-12. PubMed ID: 21717109
    [Abstract] [Full Text] [Related]

  • 16. Current clinical management of gastrointestinal stromal tumors.
    Tosoni A, Nicolardi L, Brandes AA.
    Expert Rev Anticancer Ther; 2004 Aug 15; 4(4):595-605. PubMed ID: 15270663
    [Abstract] [Full Text] [Related]

  • 17. Imatinib mesylate.
    Waller CF.
    Recent Results Cancer Res; 2010 Aug 15; 184():3-20. PubMed ID: 20072827
    [Abstract] [Full Text] [Related]

  • 18. Imatinib-induced regression of AIDS-related Kaposi's sarcoma.
    Koon HB, Bubley GJ, Pantanowitz L, Masiello D, Smith B, Crosby K, Proper J, Weeden W, Miller TE, Chatis P, Egorin MJ, Tahan SR, Dezube BJ.
    J Clin Oncol; 2005 Feb 10; 23(5):982-9. PubMed ID: 15572730
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.